Myriad Genetics Inc
NASDAQ: MYGN · HEALTHCARE · DIAGNOSTICS & RESEARCH
Updated 2026-06-04
Myriad Genetics Inc (MYGN) Insider transactions
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-14 | BISARO, PAUL | Director | Buy | 7,500 | $3.69 | $27637.50 |
| 2026-05-01 | DONNELLY, BRIAN J | Chief Commerical Officer | Sale | 55,975 | $4.80 | $268680.00 |
| 2026-04-14 | VERRATTI, MARK | Chief Operating Officer | Sale | 1,069 | $4.91 | $5248.79 |
| 2026-04-14 | MUZZEY, DALE | Chief Scientific Officer | Sale | 946 | $4.91 | $4644.86 |
| 2026-03-22 | WHEELER, BENJAMIN RICHARD | Chief Financial Officer | Sale | 549 | $4.58 | $2514.42 |
| 2026-03-22 | VERRATTI, MARK | Chief Operating Officer | Sale | 2,055 | $4.58 | $9411.90 |
| 2026-03-22 | MUZZEY, DALE | Chief Scientific Officer | Sale | 2,019 | $4.58 | $9247.02 |
| 2026-03-15 | WHEELER, BENJAMIN RICHARD | Chief Financial Officer | Sale | 2,192 | $4.66 | $10214.72 |
| 2026-03-15 | WHEELER, BENJAMIN RICHARD | Chief Financial Officer | Sale | 877 | $4.66 | $4086.82 |
| 2026-03-15 | VERRATTI, MARK | Chief Operating Officer | Sale | 9,096 | $4.66 | $42387.36 |
| 2026-03-15 | VERRATTI, MARK | Chief Operating Officer | Sale | 5,611 | $4.66 | $26147.26 |
| 2026-03-15 | MUZZEY, DALE | Chief Scientific Officer | Sale | 11,949 | $4.66 | $55682.34 |
| 2026-03-15 | MUZZEY, DALE | Chief Scientific Officer | Sale | 4,783 | $4.66 | $22288.78 |
| 2026-03-15 | HAAS, KEVIN RICHARD | Chief Technology Officer | Sale | 8,382 | $4.66 | $39060.12 |
| 2026-03-15 | HAAS, KEVIN RICHARD | Chief Technology Officer | Sale | 3,355 | $4.66 | $15634.30 |
| 2026-03-14 | WHEELER, BENJAMIN RICHARD | Chief Financial Officer | Sale | 1,097 | $4.66 | $5112.02 |
| 2026-03-14 | VERRATTI, MARK | Chief Operating Officer | Sale | 5,418 | $4.66 | $25247.88 |
| 2026-03-14 | SOLAIMAN, SHEREEN | Chief People Officer | Sale | 5,784 | $4.66 | $26953.44 |
| 2026-03-14 | RAHA, SAMRAAT S. | Director, President and CEO | Sale | 10,816 | $4.66 | $50402.56 |
| 2026-03-14 | MUZZEY, DALE | Chief Scientific Officer | Sale | 8,288 | $4.66 | $38622.08 |
| 2026-03-14 | HAAS, KEVIN RICHARD | Chief Technology Officer | Sale | 4,161 | $4.66 | $19390.26 |
| 2026-03-13 | WHEELER, BENJAMIN RICHARD | Chief Financial Officer | Sale | 586 | $4.66 | $2730.76 |
| 2026-03-13 | VERRATTI, MARK | Chief Operating Officer | Sale | 9,164 | $4.66 | $42704.24 |
| 2026-03-13 | SOLAIMAN, SHEREEN | Chief People Officer | Sale | 8,899 | $4.66 | $41469.34 |
| 2026-03-13 | RAHA, SAMRAAT S. | Director, President and CEO | Sale | 36,304 | $4.66 | $169176.64 |
| 2026-03-13 | MUZZEY, DALE | Chief Scientific Officer | Sale | 12,779 | $4.66 | $59550.14 |
| 2026-03-13 | HAAS, KEVIN RICHARD | Chief Technology Officer | Sale | 6,412 | $4.66 | $29879.92 |
| 2026-03-13 | FOX, JENNIFER LYNNE | Chief Legal Officer | Sale | 5,995 | $4.66 | $27936.70 |
| 2026-03-12 | WHEELER, BENJAMIN RICHARD | Chief Financial Officer | Buy | 206,186 | — | — |
| 2026-03-12 | VERRATTI, MARK | Chief Operating Officer | Buy | 247,423 | — | — |
| 2026-03-12 | SOLAIMAN, SHEREEN | Chief People Officer | Buy | 173,196 | — | — |
| 2026-03-12 | RAHA, SAMRAAT S. | Director, President and CEO | Buy | 618,557 | — | — |
| 2026-03-12 | MUZZEY, DALE | Chief Scientific Officer | Buy | 173,196 | — | — |
| 2026-03-12 | FOX, JENNIFER LYNNE | Chief Legal Officer | Buy | 195,876 | — | — |
| 2026-03-12 | DONNELLY, BRIAN J | Chief Commerical Officer | Buy | 226,804 | — | — |
| 2026-03-09 | RAHA, SAMRAAT S. | Director, President and CEO | Buy | 40,000 | $5.00 | $199844.00 |
| 2026-03-01 | SOLAIMAN, SHEREEN | Chief People Officer | Sale | 1,675 | $4.61 | $7721.75 |
| 2026-02-27 | PHANSTIEL, S. LOUISE | Director | Buy | 48,000 | $4.66 | $223728.00 |
| 2026-02-26 | PHANSTIEL, S. LOUISE | Director | Buy | 50,407 | $4.80 | $242104.82 |
| 2026-02-25 | PHANSTIEL, S. LOUISE | Director | Buy | 6,100 | $4.74 | $28889.60 |
| 2026-02-02 | WHEELER, BENJAMIN RICHARD | Chief Financial Officer | Buy | 4,994 | — | — |
| 2026-02-02 | VERRATTI, MARK | Chief Operating Officer | Buy | 32,810 | — | — |
| 2026-02-02 | MUZZEY, DALE | Chief Scientific Officer | Buy | 23,697 | — | — |
| 2026-02-02 | HAAS, KEVIN RICHARD | Chief Technology Officer | Buy | 23,697 | — | — |
| 2026-01-01 | MUZZEY, DALE | Chief Scientific Officer | Sale | 418 | $6.15 | $2570.70 |
| 2025-12-25 | WHEELER, BENJAMIN RICHARD | Chief Financial Officer | Sale | 21 | $6.55 | $137.55 |
| 2025-12-11 | RAHA, SAMRAAT S. | Director, President and CEO | Sale | 29,634 | $7.30 | $216328.20 |
| 2025-09-21 | WHEELER, BENJAMIN RICHARD | Chief Financial Officer | Sale | 2,559 | $7.77 | $19883.43 |
| 2025-09-21 | VERRATTI, MARK | Chief Operating Officer | Sale | 1,085 | $7.77 | $8430.45 |
| 2025-09-21 | MUNK, NATALIE | Chief Accounting Officer | Sale | 962 | $7.77 | $7474.74 |
| 2025-09-21 | ANCONA, MARGARET | EVP, Strategy & Transformation | Sale | 958 | $7.77 | $7443.66 |
| 2025-09-03 | FOX, JENNIFER LYNNE | Chief Legal Officer | Sale | 4,435 | $6.80 | $30158.00 |
| 2025-08-16 | WHEELER, BENJAMIN RICHARD | Chief Financial Officer | Buy | 60,000 | — | — |
| 2025-06-05 | SKOVRONSKY, DANIEL | Director | Buy | 49,796 | — | — |
| 2025-06-05 | REITAN, COLLEEN F | Director | Buy | 49,796 | — | — |
| 2025-06-05 | PHANSTIEL, S. LOUISE | Director | Buy | 49,796 | — | — |
| 2025-06-05 | NEWCOMER, LEE NISLEY | Director | Buy | 49,796 | — | — |
| 2025-06-05 | KUMAR, RASHMI | Director | Buy | 49,796 | — | — |
| 2025-06-05 | DREISMANN, HEINRICH | Director | Buy | 49,796 | — | — |
| 2025-06-05 | DAVIS, MARK STEVEN | Director | Buy | 24,148 | — | — |
| 2025-06-05 | BISARO, PAUL | Director | Buy | 49,796 | — | — |
| 2025-05-31 | RAHA, SAMRAAT S. | Director, President and CEO | Buy | 1,498 | $3.56 | $5335.88 |
| 2025-05-01 | DONNELLY, BRIAN J | Chief Commerical Officer | Buy | 236,167 | — | — |
| 2025-05-01 | DONNELLY, BRIAN J | Chief Commerical Officer | Buy | 269,905 | — | — |
| 2025-05-01 | DONNELLY, BRIAN J | Chief Commerical Officer | Buy | 127,629 | — | — |
| 2025-04-30 | VERRATTI, MARK | Chief Operating Officer | Buy | 105,785 | — | — |
| 2025-04-30 | RAHA, SAMRAAT S. | Director, President and CEO | Buy | 141,050 | — | — |
| 2025-04-14 | VERRATTI, MARK | Chief Commercial Officer | Sale | 1,085 | $8.08 | $8766.80 |
| 2025-04-14 | MUZZEY, DALE | Chief Scientific Officer | Sale | 942 | $8.08 | $7611.36 |
| 2025-03-25 | MUNK, NATALIE | Chief Accounting Officer | Sale | 362 | $9.73 | $3522.26 |
| 2025-03-24 | VERRATTI, MARK | Chief Commercial Officer | Sale | 1,605 | $9.98 | $16017.90 |
| 2025-03-24 | VERRATTI, MARK | Chief Commercial Officer | Sale | 1,096 | $9.98 | $10938.08 |
| 2025-03-24 | MUZZEY, DALE | Chief Scientific Officer | Sale | 800 | $9.98 | $7984.00 |
| 2025-03-24 | MUZZEY, DALE | Chief Scientific Officer | Sale | 545 | $9.98 | $5439.10 |
| 2025-03-24 | MUNK, NATALIE | Chief Accounting Officer | Sale | 589 | $9.98 | $5878.22 |
| 2025-03-24 | MUNK, NATALIE | Chief Accounting Officer | Sale | 393 | $9.98 | $3922.14 |
| 2025-03-24 | HAAS, KEVIN RICHARD | Chief Technology Officer | Sale | 1,724 | $9.98 | $17205.52 |
| 2025-03-24 | HAAS, KEVIN RICHARD | Chief Technology Officer | Sale | 1,177 | $9.98 | $11746.46 |
| 2025-03-24 | DIAZ, PAUL J | Director, President and CEO | Sale | 26,827 | $9.98 | $267733.46 |
| 2025-03-24 | DIAZ, PAUL J | Director, President and CEO | Sale | 18,312 | $9.98 | $182753.76 |
| 2025-03-22 | VERRATTI, MARK | Chief Commercial Officer | Sale | 3,623 | $10.01 | $36266.23 |
| 2025-03-22 | VERRATTI, MARK | Chief Commercial Officer | Sale | 1,366 | $10.01 | $13673.66 |
| 2025-03-22 | MUZZEY, DALE | Chief Scientific Officer | Sale | 5,334 | $10.01 | $53393.34 |
| 2025-03-22 | MUZZEY, DALE | Chief Scientific Officer | Sale | 2,011 | $10.01 | $20130.11 |
| 2025-03-22 | MUNK, NATALIE | Chief Accounting Officer | Sale | 1,135 | $10.01 | $11361.35 |
| 2025-03-22 | MUNK, NATALIE | Chief Accounting Officer | Sale | 428 | $10.01 | $4284.28 |
| 2025-03-22 | HAAS, KEVIN RICHARD | Chief Technology Officer | Sale | 4,493 | $10.01 | $44974.93 |
| 2025-03-22 | HAAS, KEVIN RICHARD | Chief Technology Officer | Sale | 1,694 | $10.01 | $16956.94 |
| 2025-03-22 | DIAZ, PAUL J | Director, President and CEO | Sale | 52,682 | $10.01 | $527346.82 |
| 2025-03-22 | DIAZ, PAUL J | Director, President and CEO | Sale | 19,859 | $10.01 | $198788.59 |
| 2025-03-22 | ANCONA, MARGARET | SVP, Chief of Staff | Sale | 1,904 | $10.01 | $19059.04 |
| 2025-03-22 | ANCONA, MARGARET | SVP, Chief of Staff | Sale | 718 | $10.01 | $7187.18 |
| 2025-03-15 | VERRATTI, MARK | Chief Commercial Officer | Sale | 3,729 | $10.07 | $37551.03 |
| 2025-03-15 | MUZZEY, DALE | Chief Scientific Officer | Sale | 4,764 | $10.07 | $47973.48 |
| 2025-03-15 | MUNK, NATALIE | Chief Accounting Officer | Sale | 684 | $10.07 | $6887.88 |
| 2025-03-15 | HAAS, KEVIN RICHARD | Chief Technology Officer | Sale | 3,335 | $10.07 | $33583.45 |
| 2025-03-15 | DIAZ, PAUL J | Director, President and CEO | Sale | 30,118 | $10.07 | $303288.26 |
| 2025-03-15 | ANCONA, MARGARET | SVP, Chief of Staff | Sale | 1,572 | $10.07 | $15830.04 |
| 2025-03-14 | VERRATTI, MARK | Chief Commercial Officer | Sale | 5,847 | $10.07 | $58879.29 |
| 2025-03-14 | SOLAIMAN, SHEREEN | Chief People Officer | Sale | 6,060 | $10.07 | $61024.20 |
Frequently asked questions
Are MYGN insiders buying or selling?
Over the transactions on record, MYGN insiders have been net sellers, with about $3.42M in stock sold across 69 sales, against 6 open-market purchases.
Does insider selling at MYGN mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which MYGN insiders are selling the most?
Recent selling is concentrated in a few names. DIAZ, PAUL J accounts for the largest share on record, with about $1.48M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.